Biopharma happenings in Asia-Pacific, such as deals and partnerships, grants, preclinical data and other news in brief, including: 3D Medicines, Akers, Aldeyra, Algernon, Alphamab, Altimmune, Aptorum, Arcturus, Atyr, Beigene, Bellerophon, Benitec, Bioduro, Biogen, Biomérieux, Biosig, BMS, Cansino, Cerecor, Clover, Cobra, Covar, Cytodyn, Dynavax, Eisai, Eli Lilly, Gigagen, Gilead, Grifols, GSK, I-Mab, Imbio, Immuron, IMV, Innoplexus, Inovio, J&J, Kissei, Mabpharm, Mateon, Merck, Novartis, Noveome, Numab, Olix, Ono, Pfizer, Premas, Redhill, Resverlogix, Rising, Sanofi, Sanofi Pasteur, Simcere, Sorrento, Translate Bio, Vaxil, Vero, Vir, Vyripharm, Windtree, Wuxi.